Thomas Jefferson University to partner with NIBRT

The Jefferson Institute for Bioprocessing will prepare engineering students and industry professionals to lead in this emerging field. Jefferson (Philadelphia University + Thomas Jefferson University) today announced it intends to close that gap by creating the Jefferson Institute for Bioprocessing, the first – and only – education and training institute for biopharmaceutical processing in North America to be established in partnership with the internationally recognized National Institute for Bioprocessing Research and Training (NIBRT).

Stephen K. Klasko, MD, MBA, president and CEO of Thomas Jefferson University and Jefferson Health, says the partnership with NIBRT perfectly captures the philosophy of what defines a Jefferson education – making sure students are prepared to lead in tomorrow’s world.

“Jefferson is built on anticipating the emerging professions that will be commonplace 10 years from now and educating students in those disciplines today,” said Klasko. “In an increasingly global world, Jefferson and NIBRT are leveraging our respective strengths and creatively partnering to bring unprecedented value to students and industry.”

“There is a significant demand for global talent to support the growth of the biopharmaceutical manufacturing industry and our relationship with Jefferson will help address this demand throughout the United States,” said Dominic Carolan, NIBRT CEO. “The combination of engineering expertise from Philadelphia University and biosciences experience from Thomas Jefferson University, now merged into Jefferson, made this an especially attractive partnership option for NIBRT. The NIBRT and Jefferson teams have been working closely over the last 18 months and we look forward to the successful launch of this groundbreaking project.”